 | • レポートコード：D0804-14927 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、103ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、バイオ医薬品CMOサービスの世界市場を広く調査・分析し、今後の市場展望をまとめております。バイオ医薬品CMOサービスの種類別市場規模（生物製剤製造、バイオシミラー製造、その他）、用途別市場規模（臨床製造、商業製造、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Lonza、Samsung BioLogics、Rentschler Biotechnologie、Boehringer Ingelheim、Biomeva、AGC Biologics、Binex、Catalent、JRS Pharma、AbbVie、WuXi Biologics、KBI Biopharma、PRA Health Sciences、ProBioGen ・地域別グローバル市場分析 2015年-2020年 ・バイオ医薬品CMOサービスの北米市場（アメリカ、カナダ、メキシコ） ・バイオ医薬品CMOサービスのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・バイオ医薬品CMOサービスのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・バイオ医薬品CMOサービスの南米市場（ブラジル、アルゼンチン） ・バイオ医薬品CMOサービスの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：生物製剤製造、バイオシミラー製造、その他 ・用途別分析：臨床製造、商業製造、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Biopharmaceutical CMO Services market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Biopharmaceutical CMO Services sales will be xx in 2020 from Biopharmaceutical CMO Services million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Biopharmaceutical CMO Services market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Biopharmaceutical CMO Services industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Biopharmaceutical CMO Services and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Biopharmaceutical CMO Services market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Biopharmaceutical CMO Services market has been segmented into:
Biologics Manufacturing
Biosimilars Manufacturing
Others
By Application, Biopharmaceutical CMO Services has been segmented into:
Clinical Manufacturing
Commercial Manufacturing
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biopharmaceutical CMO Services market presented in the report. This section sheds light on the sales growth of different regional and country-level Biopharmaceutical CMO Services markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biopharmaceutical CMO Services market.
The report offers in-depth assessment of the growth and other aspects of the Biopharmaceutical CMO Services market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Biopharmaceutical CMO Services Market Share Analysis
Biopharmaceutical CMO Services competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biopharmaceutical CMO Services sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biopharmaceutical CMO Services sales, revenue and market share for each player covered in this report.
The major players covered in Biopharmaceutical CMO Services are:
Lonza
Samsung BioLogics
Rentschler Biotechnologie
Boehringer Ingelheim
Biomeva
AGC Biologics
Binex
Catalent
JRS Pharma
AbbVie
WuXi Biologics
KBI Biopharma
PRA Health Sciences
ProBioGen
Among other players domestic and global, Biopharmaceutical CMO Services market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Biopharmaceutical CMO Services Market Overview
1.1 Product Overview and Scope of Biopharmaceutical CMO Services
1.2 Classification of Biopharmaceutical CMO Services by Type
1.2.1 Global Biopharmaceutical CMO Services Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Biopharmaceutical CMO Services Revenue Market Share by Type in 2019
1.2.3 Biologics Manufacturing
1.2.4 Biosimilars Manufacturing
1.2.5 Others
1.3 Global Biopharmaceutical CMO Services Market by Application
1.3.1 Overview: Global Biopharmaceutical CMO Services Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Clinical Manufacturing
1.3.3 Commercial Manufacturing
1.3.4 Others
1.4 Global Biopharmaceutical CMO Services Market by Regions
1.4.1 Global Biopharmaceutical CMO Services Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Biopharmaceutical CMO Services (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Biopharmaceutical CMO Services Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Biopharmaceutical CMO Services Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biopharmaceutical CMO Services Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Biopharmaceutical CMO Services Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biopharmaceutical CMO Services Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Biopharmaceutical CMO Services Industry Impact
1.5.1 COVID-19 Potential Implications for the Biopharmaceutical CMO Services
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Biopharmaceutical CMO Services
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Lonza
2.1.1 Lonza Details
2.1.2 Lonza Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Lonza SWOT Analysis
2.1.4 Lonza Product and Services
2.1.5 Lonza Biopharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2019)
2.2 Samsung BioLogics
2.2.1 Samsung BioLogics Details
2.2.2 Samsung BioLogics Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Samsung BioLogics SWOT Analysis
2.2.4 Samsung BioLogics Product and Services
2.2.5 Samsung BioLogics Biopharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2019)
2.3 Rentschler Biotechnologie
2.3.1 Rentschler Biotechnologie Details
2.3.2 Rentschler Biotechnologie Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Rentschler Biotechnologie SWOT Analysis
2.3.4 Rentschler Biotechnologie Product and Services
2.3.5 Rentschler Biotechnologie Biopharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2019)
2.4 Boehringer Ingelheim
2.4.1 Boehringer Ingelheim Details
2.4.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Boehringer Ingelheim SWOT Analysis
2.4.4 Boehringer Ingelheim Product and Services
2.4.5 Boehringer Ingelheim Biopharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2019)
2.5 Biomeva
2.5.1 Biomeva Details
2.5.2 Biomeva Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Biomeva SWOT Analysis
2.5.4 Biomeva Product and Services
2.5.5 Biomeva Biopharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2019)
2.6 AGC Biologics
2.6.1 AGC Biologics Details
2.6.2 AGC Biologics Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 AGC Biologics Product and Services
2.6.4 AGC Biologics Biopharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2019)
2.7 Binex
2.7.1 Binex Details
2.7.2 Binex Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Binex Product and Services
2.7.4 Binex Biopharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2019)
2.8 Catalent
2.8.1 Catalent Details
2.8.2 Catalent Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Catalent Product and Services
2.8.4 Catalent Biopharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2019)
2.9 JRS Pharma
2.9.1 JRS Pharma Details
2.9.2 JRS Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 JRS Pharma Product and Services
2.9.4 JRS Pharma Biopharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2019)
2.10 AbbVie
2.10.1 AbbVie Details
2.10.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 AbbVie Product and Services
2.10.4 AbbVie Biopharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2019)
2.11 WuXi Biologics
2.11.1 WuXi Biologics Details
2.11.2 WuXi Biologics Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 WuXi Biologics Product and Services
2.11.4 WuXi Biologics Biopharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2019)
2.12 KBI Biopharma
2.12.1 KBI Biopharma Details
2.12.2 KBI Biopharma Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 KBI Biopharma Product and Services
2.12.4 KBI Biopharma Biopharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2019)
2.13 PRA Health Sciences
2.13.1 PRA Health Sciences Details
2.13.2 PRA Health Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 PRA Health Sciences Product and Services
2.13.4 PRA Health Sciences Biopharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2019)
2.14 ProBioGen
2.14.1 ProBioGen Details
2.14.2 ProBioGen Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 ProBioGen Product and Services
2.14.4 ProBioGen Biopharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Biopharmaceutical CMO Services Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Biopharmaceutical CMO Services Players Market Share
3.2.2 Top 10 Biopharmaceutical CMO Services Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Biopharmaceutical CMO Services Revenue and Market Share by Regions
4.2 North America Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
4.3 Europe Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
4.5 South America Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
5 North America Biopharmaceutical CMO Services Revenue by Countries
5.1 North America Biopharmaceutical CMO Services Revenue by Countries (2015-2020)
5.2 USA Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
5.3 Canada Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
5.4 Mexico Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
6 Europe Biopharmaceutical CMO Services Revenue by Countries
6.1 Europe Biopharmaceutical CMO Services Revenue by Countries (2015-2020)
6.2 Germany Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
6.3 UK Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
6.4 France Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
6.5 Russia Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
6.6 Italy Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Biopharmaceutical CMO Services Revenue by Countries
7.1 Asia-Pacific Biopharmaceutical CMO Services Revenue by Countries (2015-2020)
7.2 China Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
7.3 Japan Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
7.4 Korea Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
7.5 India Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
8 South America Biopharmaceutical CMO Services Revenue by Countries
8.1 South America Biopharmaceutical CMO Services Revenue by Countries (2015-2020)
8.2 Brazil Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
8.3 Argentina Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Biopharmaceutical CMO Services by Countries
9.1 Middle East & Africa Biopharmaceutical CMO Services Revenue by Countries (2015-2020)
9.2 Saudi Arabia Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
9.3 UAE Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
9.4 Egypt Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
9.5 South Africa Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Biopharmaceutical CMO Services Revenue and Market Share by Type (2015-2020)
10.2 Global Biopharmaceutical CMO Services Market Forecast by Type (2019-2024)
10.3 Biologics Manufacturing Revenue Growth Rate (2015-2025)
10.4 Biosimilars Manufacturing Revenue Growth Rate (2015-2025)
10.5 Others Revenue Growth Rate (2015-2025)
11 Global Biopharmaceutical CMO Services Market Segment by Application
11.1 Global Biopharmaceutical CMO Services Revenue Market Share by Application (2015-2020)
11.2 Biopharmaceutical CMO Services Market Forecast by Application (2019-2024)
11.3 Clinical Manufacturing Revenue Growth (2015-2020)
11.4 Commercial Manufacturing Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Biopharmaceutical CMO Services Market Size Forecast (2021-2025)
12.1 Global Biopharmaceutical CMO Services Market Size Forecast (2021-2025)
12.2 Global Biopharmaceutical CMO Services Market Forecast by Regions (2021-2025)
12.3 North America Biopharmaceutical CMO Services Revenue Market Forecast (2021-2025)
12.4 Europe Biopharmaceutical CMO Services Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Biopharmaceutical CMO Services Revenue Market Forecast (2021-2025)
12.6 South America Biopharmaceutical CMO Services Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Biopharmaceutical CMO Services Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Biopharmaceutical CMO Services Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Biopharmaceutical CMO Services by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biopharmaceutical CMO Services Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Biopharmaceutical CMO Services Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Biopharmaceutical CMO Services Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Lonza Corporate Information, Location and Competitors
Table 7. Lonza Biopharmaceutical CMO Services Major Business
Table 8. Lonza Biopharmaceutical CMO Services Total Revenue (USD Million) (2017-2018)
Table 9. Lonza SWOT Analysis
Table 10. Lonza Biopharmaceutical CMO Services Product and Solutions
Table 11. Lonza Biopharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Samsung BioLogics Corporate Information, Location and Competitors
Table 13. Samsung BioLogics Biopharmaceutical CMO Services Major Business
Table 14. Samsung BioLogics Biopharmaceutical CMO Services Total Revenue (USD Million) (2018-2019)
Table 15. Samsung BioLogics SWOT Analysis
Table 16. Samsung BioLogics Biopharmaceutical CMO Services Product and Solutions
Table 17. Samsung BioLogics Biopharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Rentschler Biotechnologie Corporate Information, Location and Competitors
Table 19. Rentschler Biotechnologie Biopharmaceutical CMO Services Major Business
Table 20. Rentschler Biotechnologie Biopharmaceutical CMO Services Total Revenue (USD Million) (2017-2018)
Table 21. Rentschler Biotechnologie SWOT Analysis
Table 22. Rentschler Biotechnologie Biopharmaceutical CMO Services Product and Solutions
Table 23. Rentschler Biotechnologie Biopharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 25. Boehringer Ingelheim Biopharmaceutical CMO Services Major Business
Table 26. Boehringer Ingelheim Biopharmaceutical CMO Services Total Revenue (USD Million) (2017-2018)
Table 27. Boehringer Ingelheim SWOT Analysis
Table 28. Boehringer Ingelheim Biopharmaceutical CMO Services Product and Solutions
Table 29. Boehringer Ingelheim Biopharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Biomeva Corporate Information, Location and Competitors
Table 31. Biomeva Biopharmaceutical CMO Services Major Business
Table 32. Biomeva Biopharmaceutical CMO Services Total Revenue (USD Million) (2017-2018)
Table 33. Biomeva SWOT Analysis
Table 34. Biomeva Biopharmaceutical CMO Services Product and Solutions
Table 35. Biomeva Biopharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. AGC Biologics Corporate Information, Location and Competitors
Table 37. AGC Biologics Biopharmaceutical CMO Services Major Business
Table 38. AGC Biologics Biopharmaceutical CMO Services Total Revenue (USD Million) (2017-2018)
Table 39. AGC Biologics SWOT Analysis
Table 40. AGC Biologics Biopharmaceutical CMO Services Product and Solutions
Table 41. AGC Biologics Biopharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Binex Corporate Information, Location and Competitors
Table 43. Binex Biopharmaceutical CMO Services Major Business
Table 44. Binex Biopharmaceutical CMO Services Total Revenue (USD Million) (2017-2018)
Table 45. Binex SWOT Analysis
Table 46. Binex Biopharmaceutical CMO Services Product and Solutions
Table 47. Binex Biopharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Catalent Corporate Information, Location and Competitors
Table 49. Catalent Biopharmaceutical CMO Services Major Business
Table 50. Catalent Biopharmaceutical CMO Services Total Revenue (USD Million) (2017-2018)
Table 51. Catalent SWOT Analysis
Table 52. Catalent Biopharmaceutical CMO Services Product and Solutions
Table 53. Catalent Biopharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. JRS Pharma Corporate Information, Location and Competitors
Table 55. JRS Pharma Biopharmaceutical CMO Services Major Business
Table 56. JRS Pharma Biopharmaceutical CMO Services Total Revenue (USD Million) (2017-2018)
Table 57. JRS Pharma SWOT Analysis
Table 58. JRS Pharma Biopharmaceutical CMO Services Product and Solutions
Table 59. JRS Pharma Biopharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. AbbVie Corporate Information, Location and Competitors
Table 61. AbbVie Biopharmaceutical CMO Services Major Business
Table 62. AbbVie Biopharmaceutical CMO Services Total Revenue (USD Million) (2017-2018)
Table 63. AbbVie SWOT Analysis
Table 64. AbbVie Biopharmaceutical CMO Services Product and Solutions
Table 65. AbbVie Biopharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. WuXi Biologics Corporate Information, Location and Competitors
Table 67. WuXi Biologics Biopharmaceutical CMO Services Major Business
Table 68. WuXi Biologics Biopharmaceutical CMO Services Total Revenue (USD Million) (2017-2018)
Table 69. WuXi Biologics SWOT Analysis
Table 70. WuXi Biologics Biopharmaceutical CMO Services Product and Solutions
Table 71. WuXi Biologics Biopharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. KBI Biopharma Corporate Information, Location and Competitors
Table 73. KBI Biopharma Biopharmaceutical CMO Services Major Business
Table 74. KBI Biopharma Biopharmaceutical CMO Services Total Revenue (USD Million) (2017-2018)
Table 75. KBI Biopharma SWOT Analysis
Table 76. KBI Biopharma Biopharmaceutical CMO Services Product and Solutions
Table 77. KBI Biopharma Biopharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. PRA Health Sciences Corporate Information, Location and Competitors
Table 79. PRA Health Sciences Biopharmaceutical CMO Services Major Business
Table 80. PRA Health Sciences Biopharmaceutical CMO Services Total Revenue (USD Million) (2017-2018)
Table 81. PRA Health Sciences SWOT Analysis
Table 82. PRA Health Sciences Biopharmaceutical CMO Services Product and Solutions
Table 83. PRA Health Sciences Biopharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. ProBioGen Corporate Information, Location and Competitors
Table 85. ProBioGen Biopharmaceutical CMO Services Major Business
Table 86. ProBioGen Biopharmaceutical CMO Services Total Revenue (USD Million) (2017-2018)
Table 87. ProBioGen SWOT Analysis
Table 88. ProBioGen Biopharmaceutical CMO Services Product and Solutions
Table 89. ProBioGen Biopharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Global Biopharmaceutical CMO Services Revenue (Million USD) by Players (2015-2020)
Table 91. Global Biopharmaceutical CMO Services Revenue Share by Players (2015-2020)
Table 92. Global Biopharmaceutical CMO Services Revenue (Million USD) by Regions (2015-2020)
Table 93. Global Biopharmaceutical CMO Services Revenue Market Share by Regions (2015-2020)
Table 94. North America Biopharmaceutical CMO Services Revenue by Countries (2015-2020)
Table 95. North America Biopharmaceutical CMO Services Revenue Market Share by Countries (2015-2020)
Table 96. Europe Biopharmaceutical CMO Services Revenue (Million USD) by Countries (2015-2020)
Table 97. Asia-Pacific Biopharmaceutical CMO Services Revenue (Million USD) by Countries (2015-2020)
Table 98. South America Biopharmaceutical CMO Services Revenue by Countries (2015-2020)
Table 99. South America Biopharmaceutical CMO Services Revenue Market Share by Countries (2015-2020)
Table 100. Middle East and Africa Biopharmaceutical CMO Services Revenue (Million USD) by Countries (2015-2020)
Table 101. Middle East and Africa Biopharmaceutical CMO Services Revenue Market Share by Countries (2015-2020)
Table 102. Global Biopharmaceutical CMO Services Revenue (Million USD) by Type (2015-2020)
Table 103. Global Biopharmaceutical CMO Services Revenue Share by Type (2015-2020)
Table 104. Global Biopharmaceutical CMO Services Revenue Forecast by Type (2021-2025)
Table 105. Global Biopharmaceutical CMO Services Revenue by Application (2015-2020)
Table 106. Global Biopharmaceutical CMO Services Revenue Share by Application (2015-2020)
Table 107. Global Biopharmaceutical CMO Services Revenue Forecast by Application (2021-2025)
Table 108. Global Biopharmaceutical CMO Services Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Biopharmaceutical CMO Services Picture
Figure 2. Global Biopharmaceutical CMO Services Revenue Market Share by Type in 2019
Figure 3. Biologics Manufacturing Picture
Figure 4. Biosimilars Manufacturing Picture
Figure 5. Others Picture
Figure 6. Biopharmaceutical CMO Services Revenue Market Share by Application in 2019
Figure 7. Clinical Manufacturing Picture
Figure 8. Commercial Manufacturing Picture
Figure 9. Others Picture
Figure 10. Global Biopharmaceutical CMO Services Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Biopharmaceutical CMO Services Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Biopharmaceutical CMO Services Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Biopharmaceutical CMO Services Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Biopharmaceutical CMO Services Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Biopharmaceutical CMO Services Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Biopharmaceutical CMO Services Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Biopharmaceutical CMO Services Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Biopharmaceutical CMO Services Revenue Market Share in 2019
Figure 19. Global Top 10 Players Biopharmaceutical CMO Services Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Biopharmaceutical CMO Services Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Biopharmaceutical CMO Services Revenue Market Share by Regions (2015-2020)
Figure 23. Global Biopharmaceutical CMO Services Revenue Market Share by Regions in 2018
Figure 24. North America Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
Figure 25. Europe Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
Figure 27. South America Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
Figure 29. North America Biopharmaceutical CMO Services Revenue Market Share by Countries (2015-2020)
Figure 30. North America Biopharmaceutical CMO Services Revenue Market Share by Countries in 2019
Figure 31. USA Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
Figure 32. Canada Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
Figure 34. Europe Biopharmaceutical CMO Services Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Biopharmaceutical CMO Services Revenue Market Share by Countries in 2019
Figure 36. Germany Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
Figure 37. UK Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
Figure 38. France Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
Figure 39. Russia Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
Figure 40. Italy Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Biopharmaceutical CMO Services Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Biopharmaceutical CMO Services Revenue Market Share by Countries in 2019
Figure 43. China Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
Figure 44. Japan Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
Figure 45. Korea Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
Figure 46. India Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
Figure 48. South America Biopharmaceutical CMO Services Revenue Market Share by Countries (2015-2020)
Figure 49. South America Biopharmaceutical CMO Services Revenue Market Share by Countries in 2019
Figure 50. Brazil Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Biopharmaceutical CMO Services Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Biopharmaceutical CMO Services Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
Figure 55. UAE Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Biopharmaceutical CMO Services Revenue and Growth Rate (2015-2020)
Figure 58. Global Biopharmaceutical CMO Services Revenue Share by Type (2015-2020)
Figure 59. Global Biopharmaceutical CMO Services Revenue Share by Type in 2019
Figure 60. Global Biopharmaceutical CMO Services Market Share Forecast by Type (2021-2025)
Figure 61. Global Biologics Manufacturing Revenue Growth Rate (2015-2020)
Figure 62. Global Biosimilars Manufacturing Revenue Growth Rate (2015-2020)
Figure 63. Global Others Revenue Growth Rate (2015-2020)
Figure 64. Global Biopharmaceutical CMO Services Revenue Share by Application (2015-2020)
Figure 65. Global Biopharmaceutical CMO Services Revenue Share by Application in 2019
Figure 66. Global Biopharmaceutical CMO Services Market Share Forecast by Application (2021-2025)
Figure 67. Global Clinical Manufacturing Revenue Growth Rate (2015-2020)
Figure 68. Global Commercial Manufacturing Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Biopharmaceutical CMO Services Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Biopharmaceutical CMO Services Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Biopharmaceutical CMO Services Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Biopharmaceutical CMO Services Revenue Market Forecast (2021-2025)
Figure 74. Europe Biopharmaceutical CMO Services Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Biopharmaceutical CMO Services Revenue Market Forecast (2021-2025)
Figure 76. South America Biopharmaceutical CMO Services Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Biopharmaceutical CMO Services Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
バイオ医薬品ロジスティクスの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Biopharmaceutical Logistics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.7% in the forecast period of 2020 to 2025 and will expected to reach USD 91660 million by 2025, from USD 79160 million in 2019. The Biopharmac…- バイオ医薬品処理機器・消耗品の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Biopharmaceutical Processing Equipment And Consumable market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2…
- アクトベギンの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Actovegin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Actovegin market report provides a …
- コンドロイチンカリウムの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Chondroitin Potassium market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- モノシアロテトラヘキソシルガングリオシドの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Monosialotetrahexosylganglioside market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Monosialotet…